Enhancement of morphine analgesia by the alpha 2-adrenergic antagonist yohimbine

Neuroscience. 1995 May;66(1):5-8. doi: 10.1016/0306-4522(95)00053-l.

Abstract

Although interactions between opioids and adrenergic agonists in the treatment of pain have been demonstrated in humans, the contribution of specific adrenergic receptors in this interaction remains to be clarified. In a double-blind, placebo-controlled study in male patients with postoperative dental pain, we investigated the effect of preoperative administration of the alpha 2-adrenergic antagonist, yohimbine, on analgesia produced by postoperative intravenous morphine. Although yohimbine by itself did not affect the pain, the overall analgesic effect of morphine was significantly enhanced in the presence of yohimbine. This report is the first to demonstrate that an alpha 2-adrenergic antagonist enhances opiate analgesia in humans.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenergic alpha-2 Receptor Antagonists*
  • Adult
  • Analgesics / therapeutic use*
  • Double-Blind Method
  • Drug Synergism
  • Humans
  • Male
  • Morphine / therapeutic use*
  • Pain Measurement / drug effects
  • Pain, Postoperative / drug therapy*
  • Tooth Extraction
  • Yohimbine / therapeutic use*

Substances

  • Adrenergic alpha-2 Receptor Antagonists
  • Analgesics
  • Yohimbine
  • Morphine